- Home
- / CaroGen
CaroGen
Total Funding
$1.6 M
CaroGen Summary
Company Summary
- Overview
- CaroGen is a biopharmaceutical company specializing in immunotherapy. It develops AVIDIO, a platform technology that delivers a multiple-transgenes artificial virus for infectious diseases and immuno-oncology.
- Type
- Private
- Status
- Active
- Founded
- 2012
- HQ
- Farmington, CT, US | view all locations
- Website
- https://carogencorp.com
- Cybersecurity rating
Table of Contents
Key People
Valerian Nakaar, Co-Founder, CSO, SVP, Director
John Rose, Co-Founder and Chairman of the SAB
Michael Robek, Co-Founder, Member of SAB
LocationsView all
1 location detected
Farmington, CT HQ
United States
Cell & Genome Sciences Building R2802 400 Farmington Ave